Amygdala in the control of neuropathic pain

被引:0
作者
Goncalves, L. [1 ]
Bourbia, N. [2 ]
Viisanen, H. [2 ]
Ansah, O. B. [2 ]
Almeida, A. [3 ]
Pertovaara, A. [2 ]
机构
[1] UCL, Dept Neurosci Physiol Pharmacol, London, England
[2] Univ Helsinki, Inst Biomed Physiol, Helsinki, Finland
[3] Univ Minho, ICVS, Sch Hlth Sci, ICVS 3Bs, Braga, Portugal
来源
4TH INTERNATIONAL CONGRESS ON NEUROPATHIC PAIN | 2013年
关键词
amygdala; chronic pain; mood disorder; peripheral neuropathy; HEMISPHERIC LATERALIZATION; PERIPHERAL NEUROPATHY; NERVE INJURY; RAT MODEL; NEURONS; ACTIVATION; RECEPTORS; BEHAVIOR;
D O I
暂无
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Amygdala has a key role in the processing of primary emotions such as fear. Additionally, a subdivision of the central nucleus of the amygdala is particularly involved in processing of nociceptive signals. The amygdala may also contribute to regulation of pain through its reciprocal connections with other brain areas. Here we briefly review recent findings on neural plasticity of the amygdala in peripheral neuropathy. Peripheral nerve injury may induce neurogenesis in the amygdala of adult animals and this is accompanied by changes in synaptic functions and response characteristics of amygdaloid neurons. Moreover, the pain-regulatory action of amygdaloid neurotransmitters and neurotransmitter receptors (such as glutamate acting on the metabotropic glutamate receptor 1 or corticotropin-releasing factor (CRF) acting on the CRF1 receptor) may change following peripheral nerve injury. It is proposed that these plastic changes of the amygdala following peripheral nerve injury contribute to the sensory and affective aspects of pain in neuropathy and to the comorbidity of neuropathic pain and mood disorders.
引用
收藏
页码:53 / 57
页数:5
相关论文
共 50 条
  • [41] Approach to Neuropathic Pain
    Malhotra, Ashwin
    Weaver, Joshua
    [J]. SEMINARS IN NEUROLOGY, 2021, 41 (06) : 744 - 759
  • [42] Easing Human Pain: Challenges to a Novel Therapeutic Drug in Neuropathic Pain
    Takano, Yukio
    [J]. YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2014, 134 (10): : 997 - 1005
  • [43] Diabetic Neuropathic Pain: Directions for Exploring Treatments
    Chen, Yuchen
    Song, Xue-Jun
    [J]. BIOMEDICINES, 2024, 12 (03)
  • [44] NAD plus metabolism in peripheral neuropathic pain
    Dai, Yi
    Lin, Jiaqi
    Ren, Jinxuan
    Zhu, Bin
    Wu, Chengwei
    Yu, Lina
    [J]. NEUROCHEMISTRY INTERNATIONAL, 2022, 161
  • [45] Prevalence and associated predictors for patients developing chronic neuropathic pain following burns
    Klifto, Kevin M.
    Dellon, A. Lee
    Hultman, C. Scott
    [J]. BURNS & TRAUMA, 2020, 8
  • [46] Microglia and Neuropathic Pain
    Aldskogius, Hakan
    Kozlova, Elena N.
    [J]. CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2013, 12 (06) : 768 - 772
  • [47] Intra-amygdala microinfusion of neuropeptide S attenuates neuropathic pain and suppresses the response of spinal microglia and astrocytes after spinal nerve ligation in rats
    Yang, Fengrui
    Peng, Liangyu
    Luo, Jingjing
    Yi, Han
    Hu, Xiaoling
    [J]. PEPTIDES, 2016, 82 : 26 - 34
  • [48] Changes in morphine reward in a model of neuropathic pain
    Cahill, Catherine M.
    Xue, Lihua
    Grenier, Patrick
    Magnussen, Claire
    Lecour, Samantha
    Olmstead, Mary C.
    [J]. BEHAVIOURAL PHARMACOLOGY, 2013, 24 (03): : 207 - 213
  • [49] Control of Neuropathic Pain by Immune Cells and Opioids
    Machelska, Halina
    [J]. CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2011, 10 (05) : 559 - 570
  • [50] Plasticity and emerging role of BKCa channels in nociceptive control in neuropathic pain
    Chen, Shao-Rui
    Cai, You-Qing
    Pan, Hui-Lin
    [J]. JOURNAL OF NEUROCHEMISTRY, 2009, 110 (01) : 352 - 362